Centre for Translational Stem Cell Biology (CTSCB)

InnoHK Centre for Translational Stem Cell Biology (InnoHK CTSCB) leads global innovation in regenerative medicine. We drive next-generation stem cell technology to achieve real-world impact. Supported by the InnoHK initiative of the Innovation and Technology Commission and the University of Hong Kong, we transform pioneering discoveries into innovative applications and commercial successes.

Our patented Expanded Potential Stem Cell (EPSC) technology uniquely generates every human cell type, including embryonic and extra-embryonic lineages. This breakthrough technology accelerates the development of intelligent drug screening, precision medicine, and cell-based therapies, ultimately improving patient outcomes and enhancing quality of life.